Claudin 18.2 is a potential therapeutic target for zolbetuximab in pancreatic ductal adenocarcinoma.
Wang X, Zhang CS, Dong XY, Hu Y, Duan BJ, Bai J, Wu YY, Fan L, Liao XH, Kang Y, Zhang P, Li MY, Xu J, Mao ZJ, Liu HT, Zhang XL, Tian LF, Li EX.
Wang X, et al.
World J Gastrointest Oncol. 2022 Jul 15;14(7):1252-1264. doi: 10.4251/wjgo.v14.i7.1252.
World J Gastrointest Oncol. 2022.
PMID: 36051096
Free PMC article.